Shares of Boston Scientific Rise to a New 52-Week High
Shares of Boston Scientific (NYSE:BSX) traded today at $22.49, breaking its 52-week high. This new high was reached on below average trading volume as 3 million shares traded hands, while the average 30-day volume is approximately 10.5 million shares.
Boston Scientific Corporation develops, manufactures, and markets minimally invasive medical devices. The Company's products are used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology and neuromodulation.
Boston Scientific share prices have moved between a 52-week high of $22.49 and a 52-week low of $14.18 and are now trading 58% above that low price at $22.45 per share. In the last five trading sessions, the 50-day moving average (MA) has climbed 2.0% while the 200-day MA has risen 0.4%.
Boston Scientific (NYSE:BSX) is currently priced 7.1% above its average consensus analyst price target of $20.85. The stock should discover initial support at its 50-day moving average (MA) of $18.97 and subsequent support at its 200-day MA of $17.84.
SmarTrend recommended that subscribers consider buying shares of Boston Scientific on March 14th, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $18.01. Since that recommendation, shares of Boston Scientific have risen 24.1%. We continue to monitor BSX for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: 52 week high/lows Boston SCientific